Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. NeuroPace Inc shares valued at $2,665,333 were sold by ORBIMED ADVISORS LLC on May 14 ’25. At $15.85 per share, ORBIMED ADVISORS LLC sold 168,136 shares. The insider’s holdings dropped to 3,238,199 shares worth approximately $42.03 million following the completion of this transaction.
Also, Morrell Martha sold 78,334 shares, netting a total of over 1,074,844 in proceeds. Following the sale of shares at $13.72 each, the insider now holds 81,993 shares.
Before that, KCK LTD. had sold 5,270,845 shares from its account. In a trade valued at $49,545,943, the 10% Owner traded NeuroPace Inc shares for $9.40 each. Upon closing the transaction, the insider’s holdings decreased to 5,270,845 shares, worth approximately $0.0.
As published in their initiating research note from H.C. Wainwright on May 28, 2025, NeuroPace Inc [NPCE] has been a Buy and the price target has been revised to $18. Analysts at UBS started covering the stock with ‘”a Buy”‘ outlook in a report released in late January. As of March 14, 2024, Wells Fargo has increased its “an Equal weight” rating to a “an Overweight” for NPCE. Earlier on January 30, 2024, Leerink Partners initiated its rating. Their recommendation was “an Outperform” for NPCE stock.
Analyzing NPCE Stock Performance
On last trading session, NeuroPace Inc [NASDAQ: NPCE] rose 38.09% to $12.98. The stock’s lowest price that day was $10.7701, but it reached a high of $13.8099 in the same session. During the last five days, there has been a surge of approximately 28.13%. Over the course of the year, NeuroPace Inc shares have jumped approximately 106.36%. Shares of the company reached a 52-week high of $18.98 on 05/21/25 and a 52-week low of $7.56 on 08/13/25.
Support And Resistance Levels for NeuroPace Inc (NPCE)
According to the 24-hour chart, there is a support level at 11.23, which, if violated, would cause prices to drop to 9.48. In the upper region, resistance lies at 14.27. The next price resistance is at 15.56. RSI (Relative Strength Index) is 71.31 on the 14-day chart, showing overbought technical sentiment.
Is NeuroPace Inc subject to short interest?
Stocks of NeuroPace Inc saw a sharp rise in short interest on 2025-10-15 jumping by 0.14 million shares to 1.08 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 0.94 million shares. A jump of 12.8% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.16 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.16.
Which companies own the most shares of NeuroPace Inc (NPCE)?
In terms of NeuroPace Inc share price expectations, FactSet research, analysts set an average price target of 17.5 in the next 12 months, up nearly 86.17% from the previous closing price of $9.4. Analysts anticipate NeuroPace Inc stock to reach 19 by 2025, with the lowest price target being 16. In spite of this, 5 analysts ranked NeuroPace Inc stock as Buy at the end of 2025. On November 10, 2023, Cantor Fitzgerald assigned a price target of “an Overweight” to the stock and initiated coverage with a $11.
